TrialJournal of the European Academy of Dermatology and Venereology : JEADV2021

Impact of baricitinib in combination with topical steroids on atopic dermatitis symptoms, quality of life and functioning in adult patients with moderate-to-severe atopic dermatitis from the BREEZE-AD7 Phase 3 randomized trial.

A Wollenberg et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.